- Home
- SILO vs RSLS Comparison
SILO vs RSLS Comparison
Compare SILO & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- RSLS
- Stock Information
- Founded
- SILO 2010
- RSLS 2002
- Country
- SILO United States
- RSLS United States
- Employees
- SILO N/A
- RSLS N/A
- Industry
- SILO Apparel
- RSLS Medical/Dental Instruments
- Sector
- SILO Consumer Discretionary
- RSLS Health Care
- Exchange
- SILO Nasdaq
- RSLS Nasdaq
- Market Cap
- SILO 4.3M
- RSLS 4.5M
- IPO Year
- SILO N/A
- RSLS 2007
- Fundamental
- Price
- SILO $0.64
- RSLS $2.44
- Analyst Decision
- SILO
- RSLS Hold
- Analyst Count
- SILO 0
- RSLS 1
- Target Price
- SILO N/A
- RSLS N/A
- AVG Volume (30 Days)
- SILO 2.2M
- RSLS 7.5M
- Earning Date
- SILO 08-12-2025
- RSLS 08-13-2025
- Dividend Yield
- SILO N/A
- RSLS N/A
- EPS Growth
- SILO N/A
- RSLS N/A
- EPS
- SILO N/A
- RSLS N/A
- Revenue
- SILO $72,102.00
- RSLS $7,175,000.00
- Revenue This Year
- SILO $1.86
- RSLS $52.80
- Revenue Next Year
- SILO N/A
- RSLS N/A
- P/E Ratio
- SILO N/A
- RSLS N/A
- Revenue Growth
- SILO N/A
- RSLS N/A
- 52 Week Low
- SILO $0.41
- RSLS $2.23
- 52 Week High
- SILO $4.50
- RSLS $414.99
- Technical
- Relative Strength Index (RSI)
- SILO 51.15
- RSLS 36.73
- Support Level
- SILO $0.60
- RSLS $2.45
- Resistance Level
- SILO $0.61
- RSLS $3.03
- Average True Range (ATR)
- SILO 0.06
- RSLS 0.36
- MACD
- SILO 0.02
- RSLS 0.19
- Stochastic Oscillator
- SILO 43.36
- RSLS 11.05
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.